Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2012 (2012), Article ID 435702, 11 pages
http://dx.doi.org/10.1155/2012/435702
Research Article

Efficacy and Safety of a Chinese Herbal Medicine Formula (RCM-104) in the Management of Simple Obesity: A Randomized, Placebo-Controlled Clinical Trial

1Traditional & Complementary Medicine Research Program, Health Innovations Research Institute, School of Health Sciences, RMIT University, Bundoora, VIC 3083, Australia
2China Medical University and Hospital, Taichung City 40447, Taiwan
3School of Mathematics & Geospatial Sciences, RMIT University, Bundoora, VIC 3083, Australia
4School of Applied Sciences, RMIT University, Bundoora, VIC 3083, Australia
5Guangdong Provincial Academy of Chinese Medical Sciences, Guangzhou, China

Received 21 October 2011; Revised 20 January 2012; Accepted 23 January 2012

Academic Editor: Wolfgang Weidenhammer

Copyright © 2012 George Binh Lenon et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. Heshka and D. B. Allison, “Is obesity a disease?” International Journal of Obesity and Related Metabolic Disorders, vol. 25, no. 10, pp. 1401–1404, 2001. View at Google Scholar
  2. R. E. Patterson, L. L. Frank, A. R. Kristal, and E. White, “A comprehensive examination of health conditions associated with obesity in older adults,” American Journal of Preventive Medicine, vol. 27, no. 5, pp. 385–390, 2004. View at Publisher · View at Google Scholar · View at Scopus
  3. G. A. Bray and B. M. Popkin, “Dietary fat intake does affect obesity!,” American Journal of Clinical Nutrition, vol. 68, no. 6, pp. 1157–1173, 1998. View at Google Scholar · View at Scopus
  4. Australian Bureau of Statistics, “National Health Survey: Summary of Results, 2004-05,” Cat no 4364.0. In. Canberra:ABS, 2006.
  5. A. W. Thorburn, “Prevalence of obesity in Australia,” Obesity Reviews, vol. 6, no. 3, pp. 187–189, 2005. View at Publisher · View at Google Scholar · View at Scopus
  6. M. L. Baskin, J. Ard, F. Franklin, and D. B. Allison, “Prevalence of obesity in the United States,” Obesity Reviews, vol. 6, no. 1, pp. 5–7, 2005. View at Publisher · View at Google Scholar · View at Scopus
  7. A. Ballinger and S. R. Peikin, “Orlistat: its current status as an anti-obesity drug,” European Journal of Pharmacology, vol. 440, no. 2-3, pp. 109–117, 2002. View at Publisher · View at Google Scholar · View at Scopus
  8. A. Kaya, N. Aydin, P. Topsever et al., “Efficacy of sibutramine, orlistat and combination therapy on short-term weight management in obese patients,” Biomedicine and Pharmacotherapy, vol. 58, no. 10, pp. 582–587, 2004. View at Publisher · View at Google Scholar
  9. W. P. T. James, I. D. Caterson, W. Coutinho et al., “Effect of sibutramine on cardiovascular outcomes in overweight and obese subjects,” New England Journal of Medicine, vol. 363, no. 10, pp. 905–917, 2010. View at Publisher · View at Google Scholar · View at Scopus
  10. A. J. Scheen, “Cardiovascular risk-benefit profile of sibutramine,” American Journal of Cardiovascular Drugs, vol. 10, no. 5, pp. 321–334, 2010. View at Publisher · View at Google Scholar · View at Scopus
  11. S. H. Shippey and C. R. Macedonia, “Surgical treatment of extreme obesity,” Primary Care Update for OB/GYNS, vol. 10, no. 6, pp. 278–283, 2003. View at Publisher · View at Google Scholar · View at Scopus
  12. C. Guo, D. Wei, H. Chen, and X. Zeng, “A review of the study on anti-obesity therapies with traditional Chinese medicine,” Zhong Yao Cai, vol. 25, no. 7, pp. 534–537, 2002. View at Google Scholar · View at Scopus
  13. C. Hioki, K. Yoshimoto, and T. Yoshida, “Efficacy of bofu-tsusho-san, an oriental herbal medicine, in obese Japanese women with impaired glucose tolerance,” Clinical and Experimental Pharmacology and Physiology, vol. 31, no. 9, pp. 614–619, 2004. View at Publisher · View at Google Scholar · View at Scopus
  14. K. Ohno, H. J. Chung, I. Maruyama, and T. Tani, “Bofutsushosan, a traditional Chinese formulation, prevents intimal thickening and vascular smooth muscle cell proliferation induced by balloon endothelial denudation in rats,” Biological and Pharmaceutical Bulletin, vol. 28, no. 11, pp. 2162–2165, 2005. View at Publisher · View at Google Scholar · View at Scopus
  15. N. A. Talpur, B. W. Echard, V. Manohar, and H. G. Preuss, “Influence of a combination of herbs on appetite suppression and weight loss in rats,” Diabetes, Obesity and Metabolism, vol. 3, no. 3, pp. 181–185, 2001. View at Publisher · View at Google Scholar · View at Scopus
  16. H. Sun, “Relation between treatment course and therapeutic effects of acupuncture for female obesity of different types,” Journal of Traditional Chinese Medicine, vol. 28, no. 4, pp. 258–261, 2008. View at Google Scholar · View at Scopus
  17. F. Sun and J. Yu, “The effect of a special herbal tea on obesity and anovulation in androgen-sterilized rats,” Proceedings of the Society for Experimental Biology and Medicine, vol. 223, no. 3, pp. 295–301, 2000. View at Google Scholar · View at Scopus
  18. M. Kang, J. W. Oh, H. K. Lee et al., “Anti-obesity effect of PM-F2-OB, an anti-obesity herbal formulation, on rats fed a high-fat diet,” Biological and Pharmaceutical Bulletin, vol. 27, no. 8, pp. 1251–1256, 2004. View at Publisher · View at Google Scholar · View at Scopus
  19. W. X. Tian, L. C. Li, X. D. Wu, and C. C. Chen, “Weight reduction by Chinese medicinal herbs may be related to inhibition of fatty acid synthase,” Life Sciences, vol. 74, no. 19, pp. 2389–2399, 2004. View at Publisher · View at Google Scholar · View at Scopus
  20. D. B. Allison, K. R. Fontaine, S. Heshka, J. L. Mentore, and S. B. Heymsfield, “Alternative treatments for weight loss: a critical review,” Critical Reviews in Food Science and Nutrition, vol. 41, no. 1, pp. 1–28, 2001. View at Publisher · View at Google Scholar · View at Scopus
  21. D. Heber, “Herbal preparations for obesity: are they useful?” Primary Care, vol. 30, no. 2, pp. 441–463, 2003. View at Google Scholar · View at Scopus
  22. C. N. Boozer, J. A. Nasser, S. B. Heymsfield, V. Wang, G. Chen, and J. L. Solomon, “An herbal supplement containing Ma Huang-Guarana for weight loss: a randomized, double-blind trial,” International Journal of Obesity and Related Metabolic Disorders, vol. 25, no. 3, pp. 316–324, 2001. View at Publisher · View at Google Scholar
  23. C. N. Boozer, P. A. Daly, P. Homel et al., “Herbal ephedra/caffeine for weight loss: a 6-month randomized safety and efficacy trial,” International Journal of Obesity and Related Metabolic Disorders, vol. 26, no. 5, pp. 593–604, 2002. View at Publisher · View at Google Scholar
  24. A. Nazeri, A. Massumi, J. M. Wilson et al., “Arrhythmogenicity of weight-loss supplements marketed on the Internet,” Heart Rhythm, vol. 6, no. 5, pp. 658–662, 2009. View at Publisher · View at Google Scholar · View at Scopus
  25. J. Hallas, L. Bjerrum, H. Stovring, and M. Andersen, “Use of a prescribed ephedrine/caffeine combination and the risk of serious cardiovascular events: a registry-based case-crossover study,” American Journal of Epidemiology, vol. 168, no. 8, pp. 966–973, 2008. View at Publisher · View at Google Scholar · View at Scopus
  26. C. S. Coffey, D. Steiner, B. A. Baker, and D. B. Allison, “A randomized double-blind placebo-controlled clinical trial of a product containing ephedrine, caffeine, and other ingredients from herbal sources for treatment of overweight and obesity in the absence of lifestyle treatment,” International Journal of Obesity and Related Metabolic Disorders, vol. 28, no. 11, pp. 1411–1419, 2004. View at Publisher · View at Google Scholar
  27. K. Kawata, Y. Takehira, Y. Kobayashi et al., “Three cases of liver injury caused by Sennomotokounou, a Chinese dietary supplement for weight loss,” Internal Medicine, vol. 42, no. 12, pp. 1188–1192, 2003. View at Google Scholar · View at Scopus
  28. H. Y. Yang, J. D. Wang, T. C. Lo, and P. C. Chen, “Occupational kidney disease among Chinese herbalists exposed to herbs containing aristolochic acids,” Occupational and Environmental Medicine, vol. 68, no. 4, pp. 286–290, 2011. View at Publisher · View at Google Scholar · View at Scopus
  29. P. Chantre and D. Lairon, “Recent findings of green tea extract AR25 (exolise) and its activity for the treatment of obesity,” Phytomedicine, vol. 9, no. 1, pp. 3–8, 2002. View at Google Scholar · View at Scopus
  30. J. Ludbrook, “Multiple comparison procedures updated,” Clinical and Experimental Pharmacology and Physiology, vol. 25, no. 12, pp. 1032–1037, 1998. View at Google Scholar · View at Scopus
  31. D. J. Goldstein, “Beneficial health effects of modest weight loss,” International Journal of Obesity and Related Metabolic Disorders, vol. 16, no. 6, pp. 397–415, 1992. View at Google Scholar
  32. A. G. Dulloo, J. Seydoux, L. Girardier, P. Chantre, and J. Vandermander, “Green tea and thermogenesis: interactions between catechin-polyphenols, caffeine and sympathetic activity,” International Journal of Obesity and Related Metabolic Disorders, vol. 24, no. 2, pp. 252–258, 2000. View at Google Scholar
  33. Q. Shixian, B. VanCrey, J. Shi, Y. Kakuda, and Y. Jiang, “Green tea extract thermogenesis-induced weight loss by epigallocatechin gallate inhibition of catechol-O-methyltransferase,” Journal of Medicinal Food, vol. 9, no. 4, pp. 451–458, 2006. View at Google Scholar · View at Scopus
  34. D. Bensky and A. Gamble, Chinese Herbal Medicine: Materia Medica, Eastland press, Seatle, WA, USA, 1993.
  35. K. C. Huang, The pharmacology of Chinese Herbs, CRC Press, Boca Raton, Fla, USA, 1999.
  36. B. Blissmer, D. Riebe, G. Dye, L. Ruggiero, G. Greene, and M. Caldwell, “Health-related quality of life following a clinical weight loss intervention among overweight and obese adults: intervention and 24 month follow-up effects,” Health and Quality of Life Outcomes, vol. 4, article 43, 2006. View at Publisher · View at Google Scholar · View at Scopus
  37. R. R. Li, “Chinese Huaihua chemical composition, pharmacological effects and processing of progress,” Journal of Information on Traditional Chinese Medicine, vol. 9, pp. 77–82, 2002. View at Google Scholar
  38. J. Ora, P. Laveneziana, K. Wadell, M. Preston, K. A. Webb, and D. E. O'Donnell, “Effect of obesity on respiratory mechanics during rest and exercise in COPD,” Journal of Applied Physiology, vol. 111, no. 1, pp. 10–19, 2011. View at Publisher · View at Google Scholar
  39. I. Rahman, “Antioxidant therapies in COPD,” International Journal of Chronic Obstructive Pulmonary Disease, vol. 1, no. 1, pp. 15–29, 2006. View at Google Scholar
  40. T. H. Kwan, M. K. H. Tong, K. T. Leung et al., “Acute renal failure associated with prolonged intake of slimming pills containing anthraquinones,” Hong Kong Medical Journal, vol. 12, no. 5, pp. 394–397, 2006. View at Google Scholar · View at Scopus
  41. E. Choan, R. Segal, D. Jonker et al., “A prospective clinical trial of green tea for hormone refractory prostate cancer: an evaluation of the complementary/alternative therapy approach,” Urologic Oncology, vol. 23, no. 2, pp. 108–113, 2005. View at Publisher · View at Google Scholar · View at Scopus
  42. D. R. Yance Jr. and S. M. Sagar, “Targeting angiogenesis with integrative cancer therapies,” Integrative Cancer Therapies, vol. 5, no. 1, pp. 9–29, 2006. View at Publisher · View at Google Scholar · View at Scopus
  43. K. M. W. Pisters, R. A. Newman, B. Coldman et al., “Phase I trial of oral green tea extract in adult patients with solid tumors,” Journal of Clinical Oncology, vol. 19, no. 6, pp. 1830–1838, 2001. View at Google Scholar · View at Scopus
  44. C. H. Hsu, T. H. Tsai, Y. H. Kao, K. C. Hwang, T. Y. Tseng, and P. Chou, “Effect of green tea extract on obese women: a randomized, double-blind, placebo-controlled clinical trial,” Clinical Nutrition, vol. 27, no. 3, pp. 363–370, 2008. View at Publisher · View at Google Scholar · View at Scopus
  45. C. H. Hsu, Y. L. Liao, S. C. Lin, T. H. Tsai, C. J. Huang, and P. Chou, “Does supplementation with green tea extract improve insulin resistance in obese type 2 diabetics? A randomized, double-blind, and placebo-controlled clinical trial,” Alternative Medicine Review, vol. 16, no. 2, pp. 157–163, 2011. View at Google Scholar
  46. A. B. Russell, J. W. Hardin, L. Grand, and A. Fraser, Poisonous Plants of North Carolina, 1997.
  47. M. R. Putnam, T. Boosinger, J. Spano, J. Wright, A. Wiggins, and G. D'Andrea, “Evaluation of Cassia obtusifolia (sicklepod) seed consumption in Holstein calves,” Veterinary and Human Toxicology, vol. 30, no. 4, pp. 316–318, 1988. View at Google Scholar · View at Scopus
  48. K. A. Voss and L. H. Brennecke, “Toxicological and hematological effects of sicklepod (Cassia obtusifolia) seeds in Sprague-Dawley rats: a subchronic feeding study,” Toxicon, vol. 29, no. 11, pp. 1329–1336, 1991. View at Google Scholar